2020 National Practice Guideline for the Treatment of Opioid Use Disorder - Focused Update

ASAM developed the National Practice Guideline to provide information on evidence-based treatment of opioid use disorder and is the first to address all of the FDA-approved medications available to treat addiction involving opioid use and opioid overdose in a single document.

Stimulant Use Disorders

The Clinical Practice Guideline on the Management of Stimulant Use Disorder was developed to provide information on evidence-based strategies and standards of care for the prevention and treatment of stimulant use disorders (StUD), stimulant intoxication, and stimulant withdrawal. (Public Comment Period)

Alcohol Withdrawal Management

The ASAM Guideline on Alcohol Withdrawal Management is intended to aid clinicians in their clinical decision-making and management of patients experiencing alcohol withdrawal syndrome.

Appropriate Use of Drug Testing in Clinical Addiction Medicine

ASAM developed the Appropriate Use of Drug Testing in Clinical Addiction Medicine document to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients with, or at risk for, addiction.

Standards and Performance Measures

These resources will help members ensure they are delivering the best quality of care to their patients.